{"id":17538,"type":"page","link":"https:\/\/www.ortaakarsu.net\/?page_id=17538","title":{"rendered":"Aldactone 25 mg + Olmesartan"},"content":{"rendered":"<p>Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"<p>Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Aldactone 25 mg","url":"https:\/\/www.ortaakarsu.net\/?page_id=11796","facts":[{"label":"Active ingredient \/ generic name","value":"Spironolakton"},{"label":"ATC code","value":"C03DA01"}]},{"title":"Olmesartan","url":"https:\/\/www.ortaakarsu.net\/?page_id=12387","facts":[{"label":"Active ingredient \/ generic name","value":"olmesartan"},{"label":"ATC code","value":"C09CA08"},{"label":"Administration route","value":"Oral"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"Revised 8\/2026; DailyMed updated 2026-08-06; 7.1 Agents increasing serum potassium"}],"sources":[{"label":"OLMESARTAN MEDOXOMIL tablet \u2014 US prescribing information","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=812d2d57-14d6-48a9-9687-85c2d125197e"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:30999","available":true}}